Back

GRAPHICS

UTILITY OF AN ORAL PRESENTATION OF hCG (human Choriogonadotropin) FOR THE MANAGEMENT OF OBESITY. A DOUBLE-BLIND STUDY (II)

Figure 2 (A,B and C): Body circumferences

Here we display the basal ("0") and subsequent five weekly results (weeks 1 to 5) from three out of eight anthropometrical parameters examined in this work.

Panel A=Waist. Panel B=Abdomen. Panel C=Hip.
All results are expressed in cm, mean ± SD (bars at top). Regarding all corporal circumferences assessed, only Waist and Abdomen were significantly affected by the interaction of TREATMENT [diet plus pharmacological treatment] and WEEK (trial stage). These differences appeared enhanced only when data from weeks 2 to 5 was gathered to perform a separate MANOVA analysis (other details in legend of Figure 1)

(Click to enlarge)

wpeA.gif (9072 bytes)

(Click to enlarge)

wpeB.gif (8240 bytes)

(Click to enlarge)

The hCG and obesity  Research Clinic
Director: Dr. Daniel Belluscio
Phone and Fax+54-11-4804 97 84
Phone+54-11-4807 18 83

Proceedings of the First International Workshop on hCG and obesity
(click here)


 




Copyright © Dr. Daniel Belluscio 1992-2009. All rights reserved



Supervised the translation and spelling of this website

15/08/2009